Search by Drug Name or NDC

    NDC 49702-0253-15 Cabenuva Details

    Cabenuva

    Cabenuva is a KIT in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by ViiV Healthcare Company. The primary component is .

    Product Information

    NDC 49702-0253
    Product ID 49702-253_5abcc565-e413-4613-a958-8539df1cfa10
    Associated GPIs 1210990225G120
    GCN Sequence Number 081857
    GCN Sequence Number Description cabotegravir/rilpivirine SUSER VIAL 400-600/2 INTRAMUSC
    HIC3 W0I
    HIC3 Description ANTIRETROVIRAL-INTEGRASE INHIBITOR AND NNRTI COMB.
    GCN 49090
    HICL Sequence Number 046258
    HICL Sequence Number Description CABOTEGRAVIR/RILPIVIRINE
    Brand/Generic Brand
    Proprietary Name Cabenuva
    Proprietary Name Suffix n/a
    Non-Proprietary Name cabotegravir and rilpivirine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form KIT
    Route n/a
    Active Ingredient Strength n/a
    Active Ingredient Units n/a
    Substance Name n/a
    Labeler Name ViiV Healthcare Company
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA212888
    Listing Certified Through 2024-12-31

    Package

    NDC 49702-0253-15 (49702025315)

    NDC Package Code 49702-253-15
    Billing NDC 49702025315
    Package 1 KIT in 1 CARTON (49702-253-15) * 2 mL in 1 VIAL (49702-245-01) * 2 mL in 1 VIAL (49702-249-02)
    Marketing Start Date 2021-01-21
    NDC Exclude Flag N
    Pricing Information N/A